San Francisco, Calif. (June 7, 2018) -- Syapse, the leading precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health systems dedicated to advancing precision oncology through sharing best practices.
Each year, Syapse and members of the Precision Medicine Council will convene to share strategies and insights for growing precision medicine programs in the community setting. Syapse will host the inaugural event October 18-20 in San Francisco.
"We are privileged to serve a progressive group of early adopters in the field of precision medicine,” said Ken Tarkoff, CEO of Syapse. “Beyond providing health systems with the industry's leading software application, they have asked us to facilitate the exchange of early lessons within our network and to broker insights that benefit the entire group. Through the power of this collective exchange, we believe Syapse customers will help define best practices for the industry."
Inaugural members include Henry Ford Health System, Catholic Health Initiatives and Dignity Health (the Precision Medicine Alliance), Providence St. Joseph Health, Aurora Health Care, and the University of Miami Health System. These health systems represent a wide range of communities from around the United States with diverse care needs. Syapse customers who join the network in the summer of 2018 will be eligible to join the Council’s fall event, space permitting.
"We have been a founding member of the Syapse network because of the opportunity to share data on similar patients, for both patient care and data mining research purposes, through a common technology platform," said Thomas Brown, MD, MBA, Executive Director of the Swedish Cancer Institute, part of Providence St. Joseph Health. "Joining the Syapse Precision Medicine Council will also allow us to engage strategically on best practices in scaling precision medicine programs for the future."
“Oncologists and administrators know that collaboration is vital in bringing research to and making the best treatment decisions for patients,” said Damon Hostin, CEO of the Precision Medicine Alliance (PMA). “PMA recognizes that health systems can learn from like-minded peers across the country. I’m excited to join the Syapse Council and meet with other members this fall to share information about developing precision medicine programs that ensure access and opportunity to those we serve.”
Leading health systems are increasingly adopting precision medicine to provide better cancer care. With precision medicine, physicians can deliver personalized treatments based on a patient’s clinical and genomic profile, an approach that has been shown to improve patient outcomes, lower costs, and increase efficiency.
Health systems that partner with Syapse have access to the Syapse software platform, data sharing network, and the benefits of our industry partnerships. New Syapse partners will also have the opportunity to join the Syapse Precision Medicine Council to connect with other leading health systems with more advanced precision medicine programs.
Syapse is on a mission to deliver the best care for every cancer patient through precision medicine. Our software platform, data sharing network, and industry partnerships enable healthcare providers to bring precision cancer care to every patient who needs it. By bringing together leading healthcare innovators into a unified ecosystem, we are working toward a future in which all cancer patients have access to the best personalized care, regardless of location or income. Our customers—including Intermountain Healthcare, Providence St. Joseph Health, Henry Ford Health System, Aurora Health Care, Catholic Health Initiatives and Dignity Health—manage one million active cancer cases at nearly 300 hospitals in 25 states.